BNP Paribas Financial Markets Has $31.28 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

BNP Paribas Financial Markets boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COOFree Report) by 10.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 283,521 shares of the medical device company’s stock after purchasing an additional 25,939 shares during the quarter. BNP Paribas Financial Markets owned 0.14% of Cooper Companies worth $31,284,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. LRI Investments LLC increased its position in shares of Cooper Companies by 4.5% in the second quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock worth $227,000 after purchasing an additional 112 shares during the period. Mitchell & Pahl Private Wealth LLC raised its position in shares of Cooper Companies by 1.5% in the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company’s stock valued at $881,000 after buying an additional 117 shares in the last quarter. Commonwealth Equity Services LLC lifted its holdings in shares of Cooper Companies by 0.8% during the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock worth $1,362,000 after acquiring an additional 118 shares during the period. Bleakley Financial Group LLC boosted its position in shares of Cooper Companies by 2.1% during the 3rd quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock worth $636,000 after acquiring an additional 119 shares in the last quarter. Finally, First Horizon Advisors Inc. increased its stake in Cooper Companies by 4.8% in the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock valued at $236,000 after acquiring an additional 125 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Piper Sandler upped their target price on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Morgan Stanley raised their price objective on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. Stifel Nicolaus reissued a “buy” rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, November 20th. Finally, Robert W. Baird upped their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Check Out Our Latest Report on Cooper Companies

Cooper Companies Trading Up 1.0 %

Shares of NASDAQ COO opened at $104.46 on Friday. The firm has a 50 day moving average price of $105.30 and a two-hundred day moving average price of $98.52. The stock has a market cap of $20.80 billion, a P/E ratio of 58.07, a price-to-earnings-growth ratio of 2.24 and a beta of 0.99. The Cooper Companies, Inc. has a 52-week low of $82.21 and a 52-week high of $112.38. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99.

Cooper Companies (NASDAQ:COOGet Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. Cooper Companies’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.84 earnings per share. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Insider Activity

In related news, CFO Brian G. Andrews sold 24,788 shares of the business’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the transaction, the chief financial officer now owns 6,614 shares in the company, valued at $700,422.60. The trade was a 78.94 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at $520,488.54. This trade represents a 24.94 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 256,373 shares of company stock valued at $27,637,427. Company insiders own 2.00% of the company’s stock.

Cooper Companies Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Stories

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COOFree Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.